Skip to main content

Advertisement

SpringerLink
Log in

P53 codon 72 polymorphism and lung cancer risk: evidence from 27,958 subjects

  • Research Article
  • Published:
Tumor Biology

Abstract

The role of p53 codon 72 polymorphism in the development of lung cancer remains obscure due to inconsistent findings of individual case–control studies published to date. A meta-analysis was conducted to better estimate the association between the p53 codon 72 variant and lung cancer risk. All relevant publications from the PubMed, Embase, Web of Science, and Wanfang databases were retrieved. Based on the inclusion criteria, 39 publications involving 44 independent case–control studies were finally included into this meta-analysis. Data were extracted and the pooled odds ratio (OR) with the corresponding 95 % confidence interval (95 % CI) was calculated. The overall pooled ORs showed no significant relationship of the p53 codon 72 polymorphism with increased or decreased risk of lung cancer in all gene contrast models (OR Pro vs. Arg = 1.04, 95 % CI = 0.96–1.13, P OR < 0.001; OR Pro/Pro vs. Arg/Arg = 1.07, 95 % CI = 0.91–1.25, P OR < 0.001; OR Arg/Pro vs. Arg/Arg =1.04, 95 % CI = 0.94–1.15, P OR < 0.001; OR Pro/Pro + Arg/Pro vs. Arg/Arg = 1.04, 95 % CI = 0.94–1.16, P OR < 0.001; OR Pro/Pro vs. Arg/Arg + Arg/Pro = 1.07, 95 % CI = 0.93–1.23, P OR < 0.001). According to the ethnicity, no significant association was observed in subgroup analyses of the Asians, Caucasians, Africans and the mixed population. Similar finding was found in subgroup analyses of hospital-based and population-based studies. Concerning the histological types of lung cancer, the p53 codon 72 variant exerts risk effect on the lung carcinogenesis in patients with adenocarcinoma (OR Arg/Pro vs. Arg/Arg = 1.10, 95 % CI = 1.00–1.22, P OR = 0.048). Additionally, subgroup analysis by the smoking status demonstrated that the p53 codon 72 variant seemed to play a protective role in lung carcinogenesis among the non-smokers but not the smokers in the contrast model of Arg/Pro vs. Arg/Arg (OR Arg/Pro vs. Arg/Arg = 0.71, 95 % CI = 0.50–1.00, P OR = 0.049). The present meta-analysis suggests the p53 codon 72 polymorphism may weakly modify the risk for lung cancer among the adenocarcinoma patients and non-smokers. Nevertheless, this association needs further confirmation in future studies with high quality.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.

    Article  PubMed  Google Scholar 

  2. Williams MD, Sandler AB. The epidemiology of lung cancer. Cancer Treat Res. 2001;105:31–52.

    Article  CAS  PubMed  Google Scholar 

  3. McErlean A, Ginsberg MS. Epidemiology of lung cancer. Semin Roentgenol. 2011;46:173–7.

    Article  PubMed  Google Scholar 

  4. Samet JM. The epidemiology of lung cancer. Chest. 1993;103:20S–9S.

    Article  CAS  PubMed  Google Scholar 

  5. Lee G, Walser TC, Dubinett SM. Chronic inflammation, chronic obstructive pulmonary disease, and lung cancer. Curr Opin Pulm Med. 2009;15:303–7.

    Article  CAS  PubMed  Google Scholar 

  6. Harris CC. p53 tumor suppressor gene: at the crossroads of molecular carcinogenesis, molecular epidemiology, and cancer risk assessment. Environ Health Perspect. 1996;104 Suppl 3:435–9.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  7. Olivier M, Hussain SP, Caron de Fromentel C, Hainaut P, Harris CC. TP53 mutation spectra and load: a tool for generating hypotheses on the etiology of cancer. IARC Sci Publ. 2004:247–70.

  8. Kara N, Karakus N, Ulusoy AN, Ozaslan C, Gungor B, Bagci H. P53 codon 72 and HER2 codon 655 polymorphisms in Turkish breast cancer patients. DNA Cell Biol. 2010;29:387–92.

    Article  CAS  PubMed  Google Scholar 

  9. Weng Y, Lu L, Yuan G, Guo J, Zhang Z, Xie X, et al. p53 codon 72 polymorphism and hematological cancer risk: an update meta-analysis. PLoS One. 2012;7:e45820.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  10. Liu KJ, Qi HZ, Yao HL, Lei SL, Lei ZD, Li TG, et al. An updated meta-analysis of the p53 codon 72 polymorphism and gastric cancer risk. Mol Biol Rep. 2012;39:8265–75.

    Article  CAS  PubMed  Google Scholar 

  11. Weston A, Perrin LS, Forrester K, Hoover RN, Trump BF, Harris CC, et al. Allelic frequency of a p53 polymorphism in human lung cancer. Cancer Epidemiol Biomarkers Prev. 1992;1:481–3.

    CAS  PubMed  Google Scholar 

  12. Cochran WG. The comparison of percentages in matched samples. Biometrika. 1950;37:256–66.

    Article  CAS  PubMed  Google Scholar 

  13. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.

    Article  PubMed Central  PubMed  Google Scholar 

  14. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.

    Article  CAS  PubMed  Google Scholar 

  15. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.

    CAS  PubMed  Google Scholar 

  16. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  17. Stuck AE, Rubenstein LZ, Wieland D. Bias in meta-analysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity. BMJ. 1998;316:469. author reply 70–1.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  18. Birgander R, Sjalander A, Rannug A, Alexandrie AK, Sundberg MI, Seidegard J, et al. P53 polymorphisms and haplotypes in lung cancer. Carcinogenesis. 1995;16:2233–6.

    Article  CAS  PubMed  Google Scholar 

  19. Biros E, Kalina I, Biros I, Kohut A, Bogyiova E, Salagovic J, et al. Polymorphism of the p53 gene within the codon 72 in lung cancer patients. Neoplasma. 2001;48:407–11.

    CAS  PubMed  Google Scholar 

  20. Buyru N, Altinisik J, Isin M, Dalay N. p53 codon 72 polymorphism and HPV status in lung cancer. Med Sci Monit. 2008;14:CR493–7.

    CAS  PubMed  Google Scholar 

  21. Caceres DD, Quinones LA, Schroeder JC, Gil LD, Irarrazabal CE. Association between p53 codon 72 genetic polymorphism and tobacco use and lung cancer risk. Lung. 2009;187:110–5.

    Article  CAS  PubMed  Google Scholar 

  22. Fan R, Wu MT, Miller D, Wain JC, Kelsey KT, Wiencke JK, et al. The p53 codon 72 polymorphism and lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2000;9:1037–42.

    CAS  PubMed  Google Scholar 

  23. Fernandez-Rubio A, Lopez-Cima MF, Gonzalez-Arriaga P, Garcia-Castro L, Pascual T, Marron MG, et al. The TP53 Arg72Pro polymorphism and lung cancer risk in a population of Northern Spain. Lung Cancer. 2008;61:309–16.

    Article  PubMed  Google Scholar 

  24. Giuliani L, Jaxmar T, Casadio C, Gariglio M, Manna A, D'Antonio D, et al. Detection of oncogenic viruses SV40, BKV, JCV, HCMV, HPV and p53 codon 72 polymorphism in lung carcinoma. Lung Cancer. 2007;57:273–81.

    Article  PubMed  Google Scholar 

  25. Hiraki A, Matsuo K, Hamajima N, Ito H, Hatooka S, Suyama M, et al. Different risk relations with smoking for non-small-cell lung cancer: comparison of TP53 and TP73 genotypes. Asian Pac J Cancer Prev. 2003;4:107–12.

    PubMed  Google Scholar 

  26. Honma HN, De Capitani EM, Perroud Jr MW, Barbeiro AS, Toro IF, Costa DB, et al. Influence of p53 codon 72 exon 4, GSTM1, GSTT1 and GSTP1*B polymorphisms in lung cancer risk in a Brazilian population. Lung Cancer. 2008;61:152–62.

    Article  PubMed  Google Scholar 

  27. Ihsan R, Devi TR, Yadav DS, Mishra AK, Sharma J, Zomawia E, et al. Investigation on the role of p53 codon 72 polymorphism and interactions with tobacco, betel quid, and alcohol in susceptibility to cancers in a high-risk population from North East India. DNA Cell Biol. 2011;30:163–71.

    Article  CAS  PubMed  Google Scholar 

  28. Irarrazabal CE, Rojas C, Aracena R, Marquez C, Gil L. Chilean pilot study on the risk of lung cancer associated with codon 72 polymorphism in the gene of protein p53. Toxicol Lett. 2003;144:69–76.

    Article  CAS  PubMed  Google Scholar 

  29. Jain N, Singh V, Hedau S, Kumar S, Daga MK, Dewan R, et al. Infection of human papillomavirus type 18 and p53 codon 72 polymorphism in lung cancer patients from India. Chest. 2005;128:3999–4007.

    Article  CAS  PubMed  Google Scholar 

  30. Jin X, Wu X, Roth JA, Amos CI, King TM, Branch C, et al. Higher lung cancer risk for younger African-Americans with the Pro/Pro p53 genotype. Carcinogenesis. 1995;16:2205–8.

    Article  CAS  PubMed  Google Scholar 

  31. Jung HY, Whang YM, Sung JS, Shin HD, Park BL, Kim JS, et al. Association study of TP53 polymorphisms with lung cancer in a Korean population. J Hum Genet. 2008;53:508–14.

    Article  CAS  PubMed  Google Scholar 

  32. Liu D, Wang F, Guo X, Wang Q, Wang W, Xu H, et al. Association between p53 codon 72 genetic polymorphisms and tobacco use and lung cancer risk in a Chinese population. Mol Biol Rep. 2013;40:645–9.

    Article  CAS  PubMed  Google Scholar 

  33. Liu G, Miller DP, Zhou W, Thurston SW, Fan R, Xu LL, et al. Differential association of the codon 72 p53 and GSTM1 polymorphisms on histological subtype of non-small cell lung carcinoma. Cancer Res. 2001;61:8718–22.

    CAS  PubMed  Google Scholar 

  34. Mechanic LE, Bowman ED, Welsh JA, Khan MA, Hagiwara N, Enewold L, et al. Common genetic variation in TP53 is associated with lung cancer risk and prognosis in African Americans and somatic mutations in lung tumors. Cancer Epidemiol Biomarkers Prev. 2007;16:214–22.

    Article  CAS  PubMed  Google Scholar 

  35. Miller DP, Liu G, De Vivo I, Lynch TJ, Wain JC, Su L, et al. Combinations of the variant genotypes of GSTP1, GSTM1, and p53 are associated with an increased lung cancer risk. Cancer Res. 2002;62:2819–23.

    CAS  PubMed  Google Scholar 

  36. Murata M, Tagawa M, Kimura M, Kimura H, Watanabe S, Saisho H. Analysis of a germ line polymorphism of the p53 gene in lung cancer patients; discrete results with smoking history. Carcinogenesis. 1996;17:261–4.

    Article  CAS  PubMed  Google Scholar 

  37. Nadji SA, Mahmoodi M, Ziaee AA, Naghshvar F, Torabizadeh J, Yahyapour Y, et al. An increased lung cancer risk associated with codon 72 polymorphism in the TP53 gene and human papillomavirus infection in Mazandaran province. Iran Lung Cancer. 2007;56:145–51.

    Article  PubMed  Google Scholar 

  38. Ozbey U, Yuce H, Namli M, Elkiran T. Investigation of differences in P53 gene polymorphisms between schizophrenia and lung cancer patients in the Turkish population. Genet Res Int. 2011;2011:483851.

    PubMed Central  PubMed  Google Scholar 

  39. Papadakis ED, Soulitzis N, Spandidos DA. Association of p53 codon 72 polymorphism with advanced lung cancer: the Arg allele is preferentially retained in tumours arising in Arg/Pro germline heterozygotes. Br J Cancer. 2002;87:1013–8.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  40. Piao JM, Kim HN, Song HR, Kweon SS, Choi JS, Yun WJ, et al. p53 codon 72 polymorphism and the risk of lung cancer in a Korean population. Lung Cancer. 2011;73:264–7.

    Article  PubMed  Google Scholar 

  41. Pierce LM, Sivaraman L, Chang W, Lum A, Donlon T, Seifried A, et al. Relationships of TP53 codon 72 and HRAS1 polymorphisms with lung cancer risk in an ethnically diverse population. Cancer Epidemiol Biomarkers Prev. 2000;9:1199–204.

    CAS  PubMed  Google Scholar 

  42. Popanda O, Edler L, Waas P, Schattenberg T, Butkiewicz D, Muley T, et al. Elevated risk of squamous-cell carcinoma of the lung in heavy smokers carrying the variant alleles of the TP53 Arg72Pro and p21 Ser31Arg polymorphisms. Lung Cancer. 2007;55:25–34.

    Article  PubMed  Google Scholar 

  43. Shao GG, Liu LL, Xu CJ. Association of polymorphism in TP53 gene with susceptibility and radiation sensitivity of non-small-cell-lung cancer in Chinese population. J Jilin Univer. 2005;31:97–9 [Article in Chinese].

    CAS  Google Scholar 

  44. Sakiyama T, Kohno T, Mimaki S, Ohta T, Yanagitani N, Sobue T, et al. Association of amino acid substitution polymorphisms in DNA repair genes TP53, POLI, REV1 and LIG4 with lung cancer risk. Int J Cancer. 2005;114:730–7.

    Article  CAS  PubMed  Google Scholar 

  45. Sobti RC, Kaur P, Kaur S, Janmeja AK, Jindal SK, Kishan J, et al. Impact of interaction of polymorphic forms of p53 codon 72 and N-acetylation gene (NAT2) on the risk of lung cancer in the North Indian population. DNA Cell Biol. 2009;28:443–9.

    Article  CAS  PubMed  Google Scholar 

  46. Sreeja L, Syamala V, Raveendran PB, Santhi S, Madhavan J, Ankathil R. p53 Arg72Pro polymorphism predicts survival outcome in lung cancer patients in Indian population. Cancer Invest. 2008;26:41–6.

    Article  CAS  PubMed  Google Scholar 

  47. Su L, Sai Y, Fan R, Thurston SW, Miller DP, Zhou W, et al. P53 (codon 72) and P21 (codon 31) polymorphisms alter in vivo mRNA expression of p21. Lung Cancer. 2003;40:259–66.

    Article  PubMed  Google Scholar 

  48. Szymanowska A, Jassem E, Dziadziuszko R, Borg A, Limon J, Kobierska-Gulida G, et al. Increased risk of non-small cell lung cancer and frequency of somatic TP53 gene mutations in Pro72 carriers of TP53 Arg72Pro polymorphism. Lung Cancer. 2006;52:9–14.

    Article  PubMed  Google Scholar 

  49. To-Figueras J, Gene M, Gomez-Catalan J, Galan C, Firvida J, Fuentes M, et al. Glutathione-S-Transferase M1 and codon 72 p53 polymorphisms in a northwestern Mediterranean population and their relation to lung cancer susceptibility. Cancer Epidemiol Biomarkers Prev. 1996;5:337–42.

    CAS  PubMed  Google Scholar 

  50. Wang YC, Chen CY, Chen SK, Chang YY, Lin P. p53 codon 72 polymorphism in Taiwanese lung cancer patients: association with lung cancer susceptibility and prognosis. Clin Cancer Res. 1999;5:129–34.

    CAS  PubMed  Google Scholar 

  51. Li RN. Study of the relationship between repair gene single nucletide polymorphisms and genetic susceptibility to lung cancer. Zhongshan Univer. 2009. [Article in Chinese]

  52. Zhang JH, Li Y, Wang R, Wen DG, Wu ML, He M. P53 gene polymorphism with susceptibility to esophageal cancer and lung cancer in Chinese population. Zhonghua Zhong Liu Za Zhi. 2003;25:365–7 [Article in Chinese].

    CAS  PubMed  Google Scholar 

  53. Zhang X, Miao X, Guo Y, Tan W, Zhou Y, Sun T, et al. Genetic polymorphisms in cell cycle regulatory genes MDM2 and TP53 are associated with susceptibility to lung cancer. Hum Mutat. 2006;27:110–7.

    Article  PubMed  Google Scholar 

  54. Wang W, Hao CF, Wu YJ, Wu YM. Effects of p53 Arg/Pro gene polymorphism and smoking on the ocurrence of lung cancer in Henan Han population. 2010;45:746–8. [Article in Chinese].

  55. Chua HW, Ng D, Choo S, Lum SS, Li H, Soh LY, et al. Effect of MDM2 SNP309 and p53 codon 72 polymorphisms on lung cancer risk and survival among non-smoking Chinese women in Singapore. BMC Cancer. 2010;10:88.

    Article  PubMed Central  PubMed  Google Scholar 

  56. Lane DP, Benchimol S. p53: oncogene or anti-oncogene? Genes Dev. 1990;4:1–8.

    Article  CAS  PubMed  Google Scholar 

  57. Ara S, Lee PS, Hansen MF, Saya H. Codon 72 polymorphism of the TP53 gene. Nucleic Acids Res. 1990;18:4961.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Conflicts of interest

None.

Author information

Authors and Affiliations

  1. Department of Respiratory Medicine, Zhou Pu Hospital, 135 Guanyue Road, Pudong new District, Shanghai, 201318, China

    Chao Zhou, Hao Chen & An Wang

Authors
  1. Chao Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hao Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. An Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chao Zhou.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhou, C., Chen, H. & Wang, A. P53 codon 72 polymorphism and lung cancer risk: evidence from 27,958 subjects. Tumor Biol. 34, 2961–2969 (2013). https://doi.org/10.1007/s13277-013-0859-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-013-0859-z

Keywords

Search

Navigation